Trials / Conditions / Arteriosclerosis Obliterans

Arteriosclerosis Obliterans

10 registered clinical trials studyying Arteriosclerosis Obliterans — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) NCT07023965	Beijing Northland Biotech. Co., Ltd.	—
Recruiting	Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans NCT06485622	First Affiliated Hospital, Sun Yat-Sen University	—
Unknown	A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Oblit NCT02877173	Guangzhou Yipinhong Pharmaceutical CO.,LTD	Phase 2
Unknown	Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischem NCT02864654	Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation	Phase 1 / Phase 2
Unknown	Arterial Calcification in the Diabetes NCT02431234	Assistance Publique - Hôpitaux de Paris	—
Completed	HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) NCT01518205	Universita di Verona	N/A
Unknown	Sufficient Treatment of Peripheral Intervention by Cilostazol NCT00912756	Kansai Rosai Hospital	Phase 4
Completed	Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker NCT00823849	Otsuka Beijing Research Institute	Phase 4
Completed	Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages NCT00712946	GE Healthcare	—
Unknown	TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation NCT00145262	Nagoya University	—